Skip to content

Artal Group S.A.

Follow

13F filer, CIK 1053906, LUXEMBOURG, Luxembourg

Artal Group S.A. reported $931,121,604 across 2 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001053906-26-000008

Period
2026-06-30
Reported value
$931M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LXRXadded+20,421,735$49M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CAVAreduced-3,000,000-$235M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001053906-26-000008, largest first. % of portfolio is the value over $931,121,604, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CAVACAVA GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 17,507,990 shares; 2024Q4: 9,507,990 shares; 2025Q1: 9,507,990 shares; 2025Q2: 9,507,990 shares; 2025Q3: 9,507,990 shares; 2025Q4: 9,507,990 shares; 2026Q1: 9,507,990 shares; 2026Q2: 6,507,990 shares 6,507,990$511M54.85%-3,000,000Timeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 136,180,481 shares; 2024Q4: 136,180,481 shares; 2025Q1: 136,180,481 shares; 2025Q2: 136,180,481 shares; 2025Q3: 136,180,481 shares; 2025Q4: 136,180,481 shares; 2026Q1: 154,734,327 shares; 2026Q2: 175,156,062 shares 175,156,062$420M45.15%+20,421,735Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001053906-26-000008 base2026-08-13acceptance time not in the bulk data set